431 related articles for article (PubMed ID: 30298183)
1. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
3. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
5. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia.
Luck T; Riedel-Heller SG; Luppa M; Wiese B; Köhler M; Jessen F; Bickel H; Weyerer S; Pentzek M; König HH; Prokein J; Ernst A; Wagner M; Mösch E; Werle J; Fuchs A; Brettschneider C; Scherer M; Maier W
Psychol Med; 2014 Apr; 44(6):1319-29. PubMed ID: 23883793
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
8. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
11. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
Sager MA; Hermann B; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
[TBL] [Abstract][Full Text] [Related]
12. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
[TBL] [Abstract][Full Text] [Related]
13. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
14. [Multifunctional Roles of APOE in Alzheimer's Disease Pathogenesis].
Tokutake T; Kasuga K; Hara N; Ikeuchi T
Brain Nerve; 2016 Jul; 68(7):703-12. PubMed ID: 27395454
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.
Qiu C; Winblad B; Fastbom J; Fratiglioni L
Neurology; 2003 Sep; 61(5):655-60. PubMed ID: 12963757
[TBL] [Abstract][Full Text] [Related]
18. Association of the apolipoprotein E epsilon4 allele with late-onset depression.
Rigaud AS; Traykov L; Caputo L; Coste J; Latour F; Couderc R; Moulin F; Boller F; Forette F
Neuroepidemiology; 2001 Oct; 20(4):268-72. PubMed ID: 11684904
[TBL] [Abstract][Full Text] [Related]
19. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.
Combarros O; Leno C; Oterino A; Berciano J; Fernández-Luna JL; Fernández-Viadero C; Peña N; Miró J; Delgado M
Acta Neurol Scand; 1998 Jan; 97(1):68-71. PubMed ID: 9482681
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
